Daesung Maref Co., Ltd.
⚠️ High Risk
FEI: 3004116008 • Gunpo, Gyeonggi • SOUTH KOREA
FEI Number
3004116008
Location
Gunpo, Gyeonggi
Country
SOUTH KOREAAddress
298-24 Gongdan-Ro, , Gunpo, Gyeonggi, South Korea
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
FALSE
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.
RX DEVICE
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a prescription device that appears to not feature a prescription device legend as required by 21 CFR 801.109.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 801.15(c)(1)
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/9/2025 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | 341REGISTERED | Division of Southeast Imports (DSEI) |
| 2/26/2024 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southwest Imports (DSWI) | |
| 2/26/2024 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southwest Imports (DSWI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 11/18/2020 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 11/6/2020 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/24/2019 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 10/24/2019 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 1/23/2019 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Division of Southeast Imports (DSEI) | |
| 3/7/2014 | 89ISAMASSAGER, THERAPEUTIC, ELECTRIC | Los Angeles District Office (LOS-DO) | |
| 10/10/2013 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Seattle District Office (SEA-DO) | |
| 8/28/2013 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Seattle District Office (SEA-DO) | |
| 8/28/2013 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Seattle District Office (SEA-DO) | |
| 8/28/2013 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Seattle District Office (SEA-DO) | |
| 8/2/2013 | 89IRPMASSAGER, POWERED INFLATABLE TUBE | Seattle District Office (SEA-DO) |
Frequently Asked Questions
What is Daesung Maref Co., Ltd.'s FDA import refusal history?
Daesung Maref Co., Ltd. (FEI: 3004116008) has 21 FDA import refusal record(s) in our database, spanning from 8/2/2013 to 5/9/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Daesung Maref Co., Ltd.'s FEI number is 3004116008.
What types of violations has Daesung Maref Co., Ltd. received?
Daesung Maref Co., Ltd. has been cited for 11 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Daesung Maref Co., Ltd. come from?
All FDA import refusal data for Daesung Maref Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.